Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoglycemia | 1 | 2017 | 24 | 0.530 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 108 | 0.510 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 184 | 0.460 |
Why?
|
| Blood Glucose | 1 | 2017 | 389 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 760 | 0.300 |
Why?
|
| Endosonography | 1 | 2017 | 6 | 0.130 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 9 | 0.130 |
Why?
|
| Gastroenterology | 1 | 2017 | 8 | 0.130 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 115 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 51 | 0.130 |
Why?
|
| Risk | 1 | 2017 | 287 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2017 | 317 | 0.130 |
Why?
|
| Needles | 1 | 2016 | 10 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2017 | 156 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1124 | 0.120 |
Why?
|
| Religion | 1 | 2014 | 90 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1604 | 0.100 |
Why?
|
| Health Behavior | 1 | 2014 | 575 | 0.080 |
Why?
|
| Health Promotion | 1 | 2014 | 704 | 0.070 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 7 | 0.070 |
Why?
|
| DNA Breaks | 1 | 2007 | 6 | 0.070 |
Why?
|
| Aged | 2 | 2017 | 8214 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 749 | 0.060 |
Why?
|
| Phencyclidine | 1 | 2006 | 19 | 0.060 |
Why?
|
| Young Adult | 1 | 2017 | 5080 | 0.060 |
Why?
|
| Carcinoma | 1 | 2007 | 108 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 92 | 0.060 |
Why?
|
| Adolescent | 1 | 2017 | 6081 | 0.060 |
Why?
|
| Benzo(a)pyrene | 1 | 2007 | 128 | 0.060 |
Why?
|
| Middle Aged | 3 | 2017 | 12222 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2007 | 346 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 135 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2006 | 638 | 0.050 |
Why?
|
| Adult | 2 | 2017 | 13872 | 0.050 |
Why?
|
| Humans | 6 | 2017 | 43102 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2002 | 93 | 0.040 |
Why?
|
| Male | 3 | 2017 | 23409 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2002 | 166 | 0.040 |
Why?
|
| Female | 3 | 2017 | 24698 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2002 | 338 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1263 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1092 | 0.030 |
Why?
|
| Life Style | 2 | 2014 | 334 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2016 | 29 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 28 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 359 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cell Survival | 2 | 2007 | 945 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 1600 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 256 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 385 | 0.020 |
Why?
|
| Social Support | 1 | 2014 | 445 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1154 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 666 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1028 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 352 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2014 | 469 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1234 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 826 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 692 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2853 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2007 | 44 | 0.020 |
Why?
|
| Biogenic Amines | 1 | 2006 | 13 | 0.020 |
Why?
|
| Carcinogens | 1 | 2007 | 126 | 0.020 |
Why?
|
| Tritium | 1 | 2006 | 46 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2006 | 43 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2006 | 29 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2006 | 93 | 0.020 |
Why?
|
| Neurites | 1 | 2006 | 40 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 59 | 0.010 |
Why?
|
| Cell Death | 1 | 2007 | 278 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2006 | 150 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2006 | 131 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 575 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 883 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 465 | 0.010 |
Why?
|
| District of Columbia | 1 | 2002 | 80 | 0.010 |
Why?
|
| Fathers | 1 | 2002 | 38 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1082 | 0.010 |
Why?
|
| Urban Health | 1 | 2002 | 101 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2002 | 65 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2002 | 233 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1455 | 0.010 |
Why?
|
| Focus Groups | 1 | 2002 | 423 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2002 | 231 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2676 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 972 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2002 | 574 | 0.010 |
Why?
|
| Poverty | 1 | 2002 | 400 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 3735 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2002 | 497 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 1772 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2002 | 830 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 16992 | 0.000 |
Why?
|